Mark Smith, Finch Therapeutics CEO
Bear market shows no signs of abating, claiming Finch Therapeutics as the latest layoff victim
Much ink has been spilled over the continuing wave of layoffs hitting the biotech industry, and that doesn’t look to be stopping anytime soon. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
